Clinical Trial

Molecular Inflammation Board at the Center for Personalized Medicine

Study acronym: MEB@ZPM
Recruiting
View on ClinicalTrials.gov →
Summary
Molecular Inflammation Board at the Center for Personalized Medicine
Trial Details
NCT Number NCT07132333
Lead Sponsor University Hospital Tuebingen
Collaborators: University Hospital Freiburg, University Hospital Heidelberg, University Hospital Ulm
Conditions Psoriasis (PsO), Psoriasis Arthritis, Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis), Spondylarthropathies
Enrollment 3,000 participants
Start Date 2022-11-16
Primary Completion 2032-11 (estimated)
Study Completion 2032-11 (estimated)
Updated on ClinicalTrials.gov 2025-08-20